Congress made crucial change to vaccine definition weeks before COVID-19 – LifeSite

Share it with your friends Like

Thanks! Share it with your friends!

Close

“It certainly appears that they were anticipating using these mRNA jabs down the road so the need for the change. It’s also interesting that the US government and Moderna are joint owners of that vax. This whole thing is a cesspool of corruption and evil.” Admin

 

Without a quiet change to federal law just before the onset of COVID-19, the experimental, mRNA COVID jabs may never have been labelled as vaccines.

 

A previous article on LifeSiteNews.com described the major conflicts of interest observable during the process leading up to the U.S federal government’s emergency use authorization of COVID-19 mRNA vaccines. In December 2019 (before reported outbreak of COVID-19), the U.S. federal government signed a contract with one COVID-19 vaccine maker, Moderna, which “stated ‘mRNA coronavirus vaccine candidates [are] developed and jointly owned” by both Moderna and the U.S. federal government, the article explains.   

 

This article discusses the additional significant fact that, also in December of 2019, the U.S. federal government changed the definition of “biological product” in federal laws governing vaccine labeling, emergency use authorization, and approval. The U.S. federal government labels vaccines as “biological products.”

 

Read More: Congress made crucial change to vaccine definition weeks before COVID-19 – LifeSite

  • Rating:
  • Views:297 views
  • Categories: Health